drugset / Trial / NCT01202279
Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine if treatment with Mucinex D lowers the use of antibiotics in the treatment of upper respiratory infection when compared to placebo
Timeline
- Start
- 2009-10
- Primary completion
- 2010-04
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Guaifenesin | Small molecule | 1200 mg | — |
| Subject | Pseudoephedrine | Small molecule | 120 mg | — |